VIRIDIAN THERAPEUTICS INC
VRDNNASDAQ🏆 #1627 by market capEarnings Nov 4US Equity
$22.97▼ $0.09 (−0.39%)
Market closed · at close1h—
24h▼ 0.4%
7d▲ 9.1%
14d▲ 15.5%
30d▲ 21.1%
1y▲ 27.9%
🏦Market Cap
$2.54B
Small Cap
📈Revenue Growth (YoY)
+23220.3%
High Growth
📊Gross Margin
2.4%
Thin
💵FCF Margin
—
⚖️P/S Ratio
35.1x
Expensive
Otter Score
55
Weak
📊
Analyst Ratings
Price
$22.97
Total
16
Raised
1
Lowered
2
Avg PT
$37.25
H / L
$45 / $26
| Institution | Action | Rating | Date |
|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-06-30 |
RBC Capital | Reiterated | Outperform | 2026-06-30 |
Truist Securities | Reiterated | Buy | 2026-06-30 |
Needham | Reiterated | Buy | 2026-06-30 |
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-06-29 |
Evercore ISI Group | Reiterated | Outperform | 2026-05-15 |
Goldman Sachs | Reiterated | Buy | 2026-04-07 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-31 |
BTIG | Reiterated | Buy | 2025-11-04 |
Oppenheimer | Reiterated | Outperform | 2025-10-21 |
JMP Securities | Reiterated | Market Outperform | 2025-05-07 |
B. Riley Securities | Downgraded | Buy → Neutral | 2024-05-09 |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2024-05-09 |
Stifel | Reiterated | Buy | 2023-09-13 |
Credit Suisse | Reiterated | Outperform | 2023-05-10 |
SVB Leerink | Reiterated | Outperform | 2023-01-09 |
One row per institution, most recent rating